 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0030515	snoRNA binding	1	9.919632e-4	1.000000e+0	1.000000e+0	1.008102e+3	9.919632e-4	1	9.919632e-4	1.000000e+0	1	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	NHP2
GO Molecular Function	GO:0003723	RNA binding	2	7.115189e-2	1.000000e+0	1.000000e+0	1.405444e+1	7.115189e-2	1	7.115189e-2	1.000000e+0	2	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	NHP2
GO Molecular Function	GO:0003676	nucleic acid binding	3	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	3	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	NHP2
GO Molecular Function	GO:1901363	heterocyclic compound binding	4	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	4	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	NHP2
GO Molecular Function	GO:0097159	organic cyclic compound binding	5	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	5	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	NHP2
GO Molecular Function	GO:0005488	binding	6	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	6	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	NHP2
GO Biological Process	GO:0031118	rRNA pseudouridine synthesis	1	2.972863e-5	3.103669e-1	3.103669e-1	3.363760e+4	2.972863e-5	1	2.972863e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NHP2
GO Biological Process	GO:0000154	rRNA modification	2	1.628823e-4	1.000000e+0	8.502456e-1	6.139404e+3	1.628823e-4	1	1.628823e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NHP2
GO Biological Process	GO:0001522	pseudouridine synthesis	3	9.130081e-4	1.000000e+0	1.000000e+0	1.095281e+3	9.130081e-4	1	9.130081e-4	1.000000e+0	3	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	NHP2
GO Biological Process	GO:0009451	RNA modification	4	4.542794e-3	1.000000e+0	1.000000e+0	2.201288e+2	4.542794e-3	1	4.542794e-3	1.000000e+0	4	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	NHP2
GO Biological Process	GO:0006364	rRNA processing	5	6.350218e-3	1.000000e+0	1.000000e+0	1.574749e+2	6.350218e-3	1	6.350218e-3	1.000000e+0	5	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	NHP2
GO Biological Process	GO:0016072	rRNA metabolic process	6	6.747725e-3	1.000000e+0	1.000000e+0	1.481981e+2	6.747725e-3	1	6.747725e-3	1.000000e+0	6	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	NHP2
GO Biological Process	GO:0042254	ribosome biogenesis	7	9.732944e-3	1.000000e+0	1.000000e+0	1.027438e+2	9.732944e-3	1	9.732944e-3	1.000000e+0	7	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	NHP2
GO Biological Process	GO:0034470	ncRNA processing	8	1.300368e-2	1.000000e+0	1.000000e+0	7.690130e+1	1.300368e-2	1	1.300368e-2	1.000000e+0	8	2.456936e-2	1.000000e+0	1.000000e+0	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	NHP2
GO Biological Process	GO:0022613	ribonucleoprotein complex biogenesis	9	1.886121e-2	1.000000e+0	1.000000e+0	5.301888e+1	1.886121e-2	1	1.886121e-2	1.000000e+0	9	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	NHP2
GO Biological Process	GO:0034660	ncRNA metabolic process	10	1.918569e-2	1.000000e+0	1.000000e+0	5.212218e+1	1.918569e-2	1	1.918569e-2	1.000000e+0	10	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	NHP2
GO Biological Process	GO:0006396	RNA processing	11	4.781684e-2	1.000000e+0	1.000000e+0	2.091314e+1	4.781684e-2	1	4.781684e-2	1.000000e+0	11	7.257778e-2	1.000000e+0	1.000000e+0	1.352399e+1	7.394269e-2	1	667	5.000000e-1	1.499250e-3	unnamed	NHP2
GO Biological Process	GO:0044085	cellular component biogenesis	12	1.485548e-1	1.000000e+0	1.000000e+0	6.731524e+0	1.485548e-1	1	1.485548e-1	1.000000e+0	12	1.727427e-1	1.000000e+0	1.000000e+0	5.527267e+0	1.809212e-1	1	1632	5.000000e-1	6.127451e-4	unnamed	NHP2
GO Biological Process	GO:0043412	macromolecule modification	13	2.160048e-1	1.000000e+0	1.000000e+0	4.629527e+0	2.160048e-1	1	2.160048e-1	1.000000e+0	13	2.399849e-1	1.000000e+0	1.000000e+0	3.899914e+0	2.564159e-1	1	2313	5.000000e-1	4.323390e-4	unnamed	NHP2
GO Biological Process	GO:0016070	RNA metabolic process	14	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	14	3.211950e-1	1.000000e+0	1.000000e+0	2.839314e+0	3.521978e-1	1	3177	5.000000e-1	3.147624e-4	unnamed	NHP2
GO Biological Process	GO:0010467	gene expression	15	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	15	3.441967e-1	1.000000e+0	1.000000e+0	2.629117e+0	3.803559e-1	1	3431	5.000000e-1	2.914602e-4	unnamed	NHP2
GO Biological Process	GO:0090304	nucleic acid metabolic process	16	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	16	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	NHP2
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	17	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	18	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	NHP2
GO Biological Process	GO:0046483	heterocycle metabolic process	18	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	19	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	NHP2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	19	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	20	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	NHP2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	20	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	21	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	NHP2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	21	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	22	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	NHP2
GO Biological Process	GO:0071840	cellular component organization or biogenesis	22	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	17	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	NHP2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	23	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	23	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	NHP2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	24	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	24	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	NHP2
GO Biological Process	GO:0043170	macromolecule metabolic process	25	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	25	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	NHP2
GO Biological Process	GO:0044237	cellular metabolic process	26	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	26	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	NHP2
GO Biological Process	GO:0044238	primary metabolic process	27	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	27	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	NHP2
GO Biological Process	GO:0071704	organic substance metabolic process	28	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	28	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	NHP2
GO Biological Process	GO:0008152	metabolic process	29	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	29	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	NHP2
GO Biological Process	GO:0009987	cellular process	30	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	30	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	NHP2
GO Cellular Component	GO:0005732	small nucleolar ribonucleoprotein complex	1	8.870592e-4	1.000000e+0	1.000000e+0	1.127321e+3	8.870592e-4	1	8.870592e-4	1.000000e+0	1	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	NHP2
GO Cellular Component	GO:0015030	Cajal body	2	2.335127e-3	1.000000e+0	1.000000e+0	4.282422e+2	2.335127e-3	1	2.335127e-3	1.000000e+0	2	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	NHP2
GO Cellular Component	GO:0016604	nuclear body	3	2.621946e-2	1.000000e+0	1.000000e+0	3.813961e+1	2.621946e-2	1	2.621946e-2	1.000000e+0	3	3.287295e-2	1.000000e+0	1.000000e+0	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	NHP2
GO Cellular Component	GO:0030529	ribonucleoprotein complex	4	4.087608e-2	1.000000e+0	1.000000e+0	2.446418e+1	4.087608e-2	1	4.087608e-2	1.000000e+0	7	6.862335e-2	1.000000e+0	1.000000e+0	1.431825e+1	6.984092e-2	1	630	5.000000e-1	1.587302e-3	unnamed	NHP2
GO Cellular Component	GO:0030659	cytoplasmic vesicle membrane	5	4.091204e-2	1.000000e+0	1.000000e+0	2.444268e+1	4.091204e-2	1	4.091204e-2	1.000000e+0	4	4.331096e-2	1.000000e+0	1.000000e+0	2.283671e+1	4.378915e-2	1	395	5.000000e-1	2.531646e-3	unnamed	N4BP3
GO Cellular Component	GO:0012506	vesicle membrane	6	4.153725e-2	1.000000e+0	1.000000e+0	2.407478e+1	4.153725e-2	1	4.153725e-2	1.000000e+0	5	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	N4BP3
GO Cellular Component	GO:0044433	cytoplasmic vesicle part	7	4.819948e-2	1.000000e+0	1.000000e+0	2.074711e+1	4.819948e-2	1	4.819948e-2	1.000000e+0	6	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	N4BP3
GO Cellular Component	GO:0005730	nucleolus	8	5.338243e-2	1.000000e+0	1.000000e+0	1.873275e+1	5.338243e-2	1	5.338243e-2	1.000000e+0	9	7.118934e-2	1.000000e+0	1.000000e+0	1.379281e+1	7.250152e-2	1	654	5.000000e-1	1.529052e-3	unnamed	NHP2
GO Cellular Component	GO:0044451	nucleoplasm part	9	5.637067e-2	1.000000e+0	1.000000e+0	1.773972e+1	5.637067e-2	1	5.637067e-2	1.000000e+0	8	6.958601e-2	1.000000e+0	1.000000e+0	1.411659e+1	7.083865e-2	1	639	5.000000e-1	1.564945e-3	unnamed	NHP2
GO Cellular Component	GO:0016023	cytoplasmic membrane-bounded vesicle	10	8.772555e-2	1.000000e+0	1.000000e+0	1.139919e+1	8.772555e-2	1	8.772555e-2	1.000000e+0	10	9.949731e-2	1.000000e+0	1.000000e+0	9.794245e+0	1.021008e-1	1	921	5.000000e-1	1.085776e-3	unnamed	N4BP3
GO Cellular Component	GO:0031988	membrane-bounded vesicle	11	9.310199e-2	1.000000e+0	1.000000e+0	1.074091e+1	9.310199e-2	1	9.310199e-2	1.000000e+0	11	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	N4BP3
GO Cellular Component	GO:0031410	cytoplasmic vesicle	12	9.330829e-2	1.000000e+0	1.000000e+0	1.071716e+1	9.330829e-2	1	9.330829e-2	1.000000e+0	12	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	N4BP3
GO Cellular Component	GO:0031982	vesicle	13	1.007261e-1	1.000000e+0	1.000000e+0	9.927917e+0	1.007261e-1	1	1.007261e-1	1.000000e+0	13	1.159383e-1	1.000000e+0	1.000000e+0	8.367811e+0	1.195056e-1	1	1078	5.000000e-1	9.276438e-4	unnamed	N4BP3
GO Cellular Component	GO:0005654	nucleoplasm	14	1.212700e-1	1.000000e+0	1.000000e+0	8.246060e+0	1.212700e-1	1	1.212700e-1	1.000000e+0	16	1.512280e-1	1.000000e+0	1.000000e+0	6.352465e+0	1.574192e-1	1	1420	5.000000e-1	7.042254e-4	unnamed	NHP2
GO Cellular Component	GO:0031981	nuclear lumen	15	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	17	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	NHP2
GO Cellular Component	GO:0044428	nuclear part	16	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	18	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	NHP2
GO Cellular Component	GO:0031090	organelle membrane	17	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	19	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	N4BP3
GO Cellular Component	GO:0070013	intracellular organelle lumen	18	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	20	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	NHP2
GO Cellular Component	GO:0043233	organelle lumen	19	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	21	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	NHP2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	20	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	22	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	NHP2
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	21	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	25	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	NHP2
GO Cellular Component	GO:0032991	macromolecular complex	22	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	28	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	NHP2
GO Cellular Component	GO:0044446	intracellular organelle part	23	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	14	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0005634	nucleus	24	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	31	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	NHP2
GO Cellular Component	GO:0044422	organelle part	25	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	15	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0044444	cytoplasmic part	26	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	32	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	N4BP3
GO Cellular Component	GO:0016020	membrane	27	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	35	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	N4BP3
GO Cellular Component	GO:0005737	cytoplasm	28	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	36	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	N4BP3
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	29	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	23	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0043227	membrane-bounded organelle	30	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	24	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0043229	intracellular organelle	31	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	26	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0043226	organelle	32	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	27	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0044424	intracellular part	33	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	29	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0005622	intracellular	34	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	30	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0044464	cell part	35	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	33	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	N4BP3,NHP2
GO Cellular Component	GO:0005623	cell	36	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	34	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	N4BP3,NHP2
Mouse Phenotype	MP:0010770	preweaning lethality	1	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	1	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	NHP2
Mouse Phenotype	MP:0010769	abnormal survival	2	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	2	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	NHP2
Mouse Phenotype	MP:0010768	mortality/aging	3	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	3	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	NHP2
Mouse Phenotype	MP:0000001	mammalian phenotype	4	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	4	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	NHP2
Human Phenotype	HP:0007427	Reticulated skin pigmentation	1	5.531097e-5	3.399412e-1	3.399412e-1	1.807960e+4	5.531097e-5	1	5.531097e-5	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	NHP2
Human Phenotype	HP:0100670	Rough bone trabeculation	2	8.395022e-4	1.000000e+0	1.000000e+0	1.191182e+3	8.395022e-4	1	8.395022e-4	1.000000e+0	3	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	NHP2
Human Phenotype	HP:0000029	Testicular atrophy	3	1.036662e-3	1.000000e+0	1.000000e+0	9.646349e+2	1.036662e-3	1	1.036662e-3	1.000000e+0	2	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	NHP2
Human Phenotype	HP:0100671	Abnormal trabecular bone morphology	4	1.186489e-3	1.000000e+0	1.000000e+0	8.428226e+2	1.186489e-3	1	1.186489e-3	1.000000e+0	4	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	NHP2
Human Phenotype	HP:0002894	Neoplasm of the pancreas	5	1.664764e-3	1.000000e+0	1.000000e+0	6.006859e+2	1.664764e-3	1	1.664764e-3	1.000000e+0	7	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NHP2
Human Phenotype	HP:0005374	Cellular immunodeficiency	6	2.448290e-3	1.000000e+0	1.000000e+0	4.084484e+2	2.448290e-3	1	2.448290e-3	1.000000e+0	9	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NHP2
Human Phenotype	HP:0008404	Nail dystrophy	7	2.615312e-3	1.000000e+0	1.000000e+0	3.823635e+2	2.615312e-3	1	2.615312e-3	1.000000e+0	12	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	NHP2
Human Phenotype	HP:0010885	Aseptic necrosis	8	2.640091e-3	1.000000e+0	1.000000e+0	3.787748e+2	2.640091e-3	1	2.640091e-3	1.000000e+0	6	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NHP2
Human Phenotype	HP:0008066	Abnormal blistering of the skin	9	2.640375e-3	1.000000e+0	1.000000e+0	3.787341e+2	2.640375e-3	1	2.640375e-3	1.000000e+0	16	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NHP2
Human Phenotype	HP:0001876	Pancytopenia	10	2.702236e-3	1.000000e+0	1.000000e+0	3.700639e+2	2.702236e-3	1	2.702236e-3	1.000000e+0	7	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NHP2
Human Phenotype	HP:0002216	Premature graying of hair	11	2.957149e-3	1.000000e+0	1.000000e+0	3.381635e+2	2.957149e-3	1	2.957149e-3	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	NHP2
Human Phenotype	HP:0005528	Bone marrow hypocellularity	12	3.518694e-3	1.000000e+0	1.000000e+0	2.841964e+2	3.518694e-3	1	3.518694e-3	1.000000e+0	10	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	NHP2
Human Phenotype	HP:0100585	Teleangiectasia of the skin	13	3.676682e-3	1.000000e+0	1.000000e+0	2.719843e+2	3.676682e-3	1	3.676682e-3	1.000000e+0	14	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	NHP2
Human Phenotype	HP:0002721	Immunodeficiency	14	3.999873e-3	1.000000e+0	1.000000e+0	2.500079e+2	3.999873e-3	1	3.999873e-3	1.000000e+0	19	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	NHP2
Human Phenotype	HP:0001009	Telangiectasia	15	4.902759e-3	1.000000e+0	1.000000e+0	2.039668e+2	4.902759e-3	1	4.902759e-3	1.000000e+0	26	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	NHP2
Human Phenotype	HP:0010624	Aplastic/hypoplastic toenails	16	5.215341e-3	1.000000e+0	1.000000e+0	1.917420e+2	5.215341e-3	1	5.215341e-3	1.000000e+0	16	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NHP2
Human Phenotype	HP:0002514	Cerebral calcification	17	5.503631e-3	1.000000e+0	1.000000e+0	1.816982e+2	5.503631e-3	1	5.503631e-3	1.000000e+0	24	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	NHP2
Human Phenotype	HP:0002665	Lymphoma	18	5.521516e-3	1.000000e+0	1.000000e+0	1.811097e+2	5.521516e-3	1	5.521516e-3	1.000000e+0	22	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NHP2
Human Phenotype	HP:0001798	Anonychia	19	5.616390e-3	1.000000e+0	1.000000e+0	1.780503e+2	5.616390e-3	1	5.616390e-3	1.000000e+0	16	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NHP2
Human Phenotype	HP:0012145	Abnormality of multiple cell lineages in the bone marrow	20	5.767847e-3	1.000000e+0	1.000000e+0	1.733749e+2	5.767847e-3	1	5.767847e-3	1.000000e+0	21	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	NHP2
Human Phenotype	HP:0000975	Hyperhidrosis	21	6.019022e-3	1.000000e+0	1.000000e+0	1.661399e+2	6.019022e-3	1	6.019022e-3	1.000000e+0	28	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	NHP2
Human Phenotype	HP:0008734	Decreased testicular size	22	6.194998e-3	1.000000e+0	1.000000e+0	1.614206e+2	6.194998e-3	1	6.194998e-3	1.000000e+0	11	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	NHP2
Human Phenotype	HP:0200042	Skin ulcer	23	6.242651e-3	1.000000e+0	1.000000e+0	1.601884e+2	6.242651e-3	1	6.242651e-3	1.000000e+0	32	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NHP2
Human Phenotype	HP:0010468	Aplasia/Hypoplasia of the testes	24	6.530622e-3	1.000000e+0	1.000000e+0	1.531248e+2	6.530622e-3	1	6.530622e-3	1.000000e+0	12	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	NHP2
Human Phenotype	HP:0002575	Tracheoesophageal fistula	25	6.778340e-3	1.000000e+0	1.000000e+0	1.475287e+2	6.778340e-3	1	6.778340e-3	1.000000e+0	15	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	NHP2
Human Phenotype	HP:0001394	Cirrhosis	26	6.884763e-3	1.000000e+0	1.000000e+0	1.452483e+2	6.884763e-3	1	6.884763e-3	1.000000e+0	30	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	NHP2
Human Phenotype	HP:0005599	Hypopigmentation of hair	27	6.976327e-3	1.000000e+0	1.000000e+0	1.433419e+2	6.976327e-3	1	6.976327e-3	1.000000e+0	19	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	NHP2
Human Phenotype	HP:0100533	Inflammatory abnormality of the eye	28	7.180633e-3	1.000000e+0	1.000000e+0	1.392635e+2	7.180633e-3	1	7.180633e-3	1.000000e+0	34	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	NHP2
Human Phenotype	HP:0001053	Hypopigmented skin patches	29	7.459647e-3	1.000000e+0	1.000000e+0	1.340546e+2	7.459647e-3	1	7.459647e-3	1.000000e+0	27	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	NHP2
Human Phenotype	HP:0001596	Alopecia	30	7.659350e-3	1.000000e+0	1.000000e+0	1.305594e+2	7.659350e-3	1	7.659350e-3	1.000000e+0	39	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	NHP2
Human Phenotype	HP:0000600	Abnormality of the pharynx	31	7.873454e-3	1.000000e+0	1.000000e+0	1.270091e+2	7.873454e-3	1	7.873454e-3	1.000000e+0	37	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NHP2
Human Phenotype	HP:0007495	Prematurely aged appearance	32	8.020783e-3	1.000000e+0	1.000000e+0	1.246761e+2	8.020783e-3	1	8.020783e-3	1.000000e+0	22	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NHP2
Human Phenotype	HP:0002164	Nail dysplasia	33	8.087727e-3	1.000000e+0	1.000000e+0	1.236441e+2	8.087727e-3	1	8.087727e-3	1.000000e+0	29	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	NHP2
Human Phenotype	HP:0001034	Hypermelanotic macule	34	8.294523e-3	1.000000e+0	1.000000e+0	1.205615e+2	8.294523e-3	1	8.294523e-3	1.000000e+0	38	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	NHP2
Human Phenotype	HP:0001928	Abnormality of coagulation	35	8.415919e-3	1.000000e+0	1.000000e+0	1.188224e+2	8.415919e-3	1	8.415919e-3	1.000000e+0	45	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	NHP2
Human Phenotype	HP:0009887	Abnormality of hair pigmentation	36	8.681770e-3	1.000000e+0	1.000000e+0	1.151839e+2	8.681770e-3	1	8.681770e-3	1.000000e+0	25	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	NHP2
Human Phenotype	HP:0008388	Abnormality of the toenails	37	9.045029e-3	1.000000e+0	1.000000e+0	1.105580e+2	9.045029e-3	1	9.045029e-3	1.000000e+0	32	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NHP2
Human Phenotype	HP:0008386	Aplasia/Hypoplasia of the nails	38	9.234499e-3	1.000000e+0	1.000000e+0	1.082896e+2	9.234499e-3	1	9.234499e-3	1.000000e+0	35	1.028356e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	NHP2
Human Phenotype	HP:0000982	Palmoplantar keratoderma	39	9.265830e-3	1.000000e+0	1.000000e+0	1.079234e+2	9.265830e-3	1	9.265830e-3	1.000000e+0	44	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	NHP2
Human Phenotype	HP:0001399	Hepatic failure	40	9.279254e-3	1.000000e+0	1.000000e+0	1.077673e+2	9.279254e-3	1	9.279254e-3	1.000000e+0	46	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NHP2
Human Phenotype	HP:0000670	Carious teeth	41	9.723085e-3	1.000000e+0	1.000000e+0	1.028480e+2	9.723085e-3	1	9.723085e-3	1.000000e+0	36	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	NHP2
Human Phenotype	HP:0005561	Abnormality of bone marrow cell morphology	42	9.823374e-3	1.000000e+0	1.000000e+0	1.017980e+2	9.823374e-3	1	9.823374e-3	1.000000e+0	43	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	NHP2
Human Phenotype	HP:0008065	Aplasia/Hypoplasia of the skin	43	1.023569e-2	1.000000e+0	1.000000e+0	9.769732e+1	1.023569e-2	1	1.023569e-2	1.000000e+0	41	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	NHP2
Human Phenotype	HP:0001410	Decreased liver function	44	1.036810e-2	1.000000e+0	1.000000e+0	9.644966e+1	1.036810e-2	1	1.036810e-2	1.000000e+0	52	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NHP2
Human Phenotype	HP:0007400	Irregular hyperpigmentation	45	1.068274e-2	1.000000e+0	1.000000e+0	9.360890e+1	1.068274e-2	1	1.068274e-2	1.000000e+0	52	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NHP2
Human Phenotype	HP:0001732	Abnormality of the pancreas	46	1.082484e-2	1.000000e+0	1.000000e+0	9.238008e+1	1.082484e-2	1	1.082484e-2	1.000000e+0	48	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	NHP2
Human Phenotype	HP:0000971	Abnormality of the sweat gland	47	1.086803e-2	1.000000e+0	1.000000e+0	9.201300e+1	1.086803e-2	1	1.086803e-2	1.000000e+0	46	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NHP2
Human Phenotype	HP:0002024	Malabsorption	48	1.118208e-2	1.000000e+0	1.000000e+0	8.942881e+1	1.118208e-2	1	1.118208e-2	1.000000e+0	52	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NHP2
Human Phenotype	HP:0001874	Abnormality of neutrophils	49	1.122807e-2	1.000000e+0	1.000000e+0	8.906248e+1	1.122807e-2	1	1.122807e-2	1.000000e+0	49	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	NHP2
Human Phenotype	HP:0001010	Hypopigmentation of the skin	50	1.161858e-2	1.000000e+0	1.000000e+0	8.606902e+1	1.161858e-2	1	1.161858e-2	1.000000e+0	42	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	NHP2
Human Phenotype	HP:0010766	Ectopic calcification	51	1.167996e-2	1.000000e+0	1.000000e+0	8.561675e+1	1.167996e-2	1	1.167996e-2	1.000000e+0	51	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	NHP2
Human Phenotype	HP:0002778	Abnormality of the trachea	52	1.234566e-2	1.000000e+0	1.000000e+0	8.100010e+1	1.234566e-2	1	1.234566e-2	1.000000e+0	31	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	NHP2
Human Phenotype	HP:0001911	Abnormality of granulocytes	53	1.244658e-2	1.000000e+0	1.000000e+0	8.034339e+1	1.244658e-2	1	1.244658e-2	1.000000e+0	56	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	NHP2
Human Phenotype	HP:0002757	Recurrent fractures	54	1.262127e-2	1.000000e+0	1.000000e+0	7.923132e+1	1.262127e-2	1	1.262127e-2	1.000000e+0	40	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	NHP2
Human Phenotype	HP:0010974	Abnormality of myeloid leukocytes	55	1.282913e-2	1.000000e+0	1.000000e+0	7.794763e+1	1.282913e-2	1	1.282913e-2	1.000000e+0	58	1.634023e-2	1.000000e+0	1.000000e+0	6.094932e+1	1.640707e-2	1	148	5.000000e-1	6.756757e-3	unnamed	NHP2
Human Phenotype	HP:0001873	Thrombocytopenia	56	1.287046e-2	1.000000e+0	1.000000e+0	7.769728e+1	1.287046e-2	1	1.287046e-2	1.000000e+0	60	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	NHP2
Human Phenotype	HP:0011873	Abnormal platelet count	57	1.307528e-2	1.000000e+0	1.000000e+0	7.648017e+1	1.307528e-2	1	1.307528e-2	1.000000e+0	61	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	NHP2
Human Phenotype	HP:0000953	Hyperpigmentation of the skin	58	1.310828e-2	1.000000e+0	1.000000e+0	7.628765e+1	1.310828e-2	1	1.310828e-2	1.000000e+0	59	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	NHP2
Human Phenotype	HP:0000962	Hyperkeratosis	59	1.427604e-2	1.000000e+0	1.000000e+0	7.004741e+1	1.427604e-2	1	1.427604e-2	1.000000e+0	65	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	NHP2
Human Phenotype	HP:0002659	Increased susceptibility to fractures	60	1.442513e-2	1.000000e+0	1.000000e+0	6.932347e+1	1.442513e-2	1	1.442513e-2	1.000000e+0	50	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	NHP2
Human Phenotype	HP:0005607	Abnormality of the tracheobronchial system	61	1.499531e-2	1.000000e+0	1.000000e+0	6.668753e+1	1.499531e-2	1	1.499531e-2	1.000000e+0	55	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	NHP2
Human Phenotype	HP:0004377	Hematological neoplasm	62	1.500982e-2	1.000000e+0	1.000000e+0	6.662306e+1	1.500982e-2	1	1.500982e-2	1.000000e+0	62	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	NHP2
Human Phenotype	HP:0001231	Abnormality of the fingernails	63	1.589452e-2	1.000000e+0	1.000000e+0	6.291475e+1	1.589452e-2	1	1.589452e-2	1.000000e+0	57	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	NHP2
Human Phenotype	HP:0001872	Abnormality of thrombocytes	64	1.595131e-2	1.000000e+0	1.000000e+0	6.269078e+1	1.595131e-2	1	1.595131e-2	1.000000e+0	67	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NHP2
Human Phenotype	HP:0000819	Diabetes mellitus	65	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	65	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	NHP2
Human Phenotype	HP:0001744	Splenomegaly	66	1.639119e-2	1.000000e+0	1.000000e+0	6.100840e+1	1.639119e-2	1	1.639119e-2	1.000000e+0	70	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	NHP2
Human Phenotype	HP:0011061	Abnormality of dental structure	67	1.718476e-2	1.000000e+0	1.000000e+0	5.819109e+1	1.718476e-2	1	1.718476e-2	1.000000e+0	64	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	NHP2
Human Phenotype	HP:0002205	Recurrent respiratory infections	68	1.903666e-2	1.000000e+0	1.000000e+0	5.253023e+1	1.903666e-2	1	1.903666e-2	1.000000e+0	73	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	NHP2
Human Phenotype	HP:0011276	Vascular skin abnormality	69	1.939619e-2	1.000000e+0	1.000000e+0	5.155651e+1	1.939619e-2	1	1.939619e-2	1.000000e+0	79	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	NHP2
Human Phenotype	HP:0001903	Anemia	70	1.958596e-2	1.000000e+0	1.000000e+0	5.105699e+1	1.958596e-2	1	1.958596e-2	1.000000e+0	81	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	NHP2
Human Phenotype	HP:0011947	Respiratory tract infection	71	2.044241e-2	1.000000e+0	1.000000e+0	4.891792e+1	2.044241e-2	1	2.044241e-2	1.000000e+0	78	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	NHP2
Human Phenotype	HP:0001511	Intrauterine growth retardation	72	2.092991e-2	1.000000e+0	1.000000e+0	4.777851e+1	2.092991e-2	1	2.092991e-2	1.000000e+0	69	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
Human Phenotype	HP:0011368	Epidermal thickening	73	2.108661e-2	1.000000e+0	1.000000e+0	4.742345e+1	2.108661e-2	1	2.108661e-2	1.000000e+0	80	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	NHP2
Human Phenotype	HP:0002240	Hepatomegaly	74	2.226096e-2	1.000000e+0	1.000000e+0	4.492169e+1	2.226096e-2	1	2.226096e-2	1.000000e+0	89	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	NHP2
Human Phenotype	HP:0100627	Displacement of the external urethral meatus	75	2.236850e-2	1.000000e+0	1.000000e+0	4.470573e+1	2.236850e-2	1	2.236850e-2	1.000000e+0	63	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	NHP2
Human Phenotype	HP:0001877	Abnormality of erythrocytes	76	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	87	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	NHP2
Human Phenotype	HP:0001743	Abnormality of the spleen	77	2.315867e-2	1.000000e+0	1.000000e+0	4.318037e+1	2.315867e-2	1	2.315867e-2	1.000000e+0	84	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	NHP2
Human Phenotype	HP:0001072	Thickened skin	78	2.357460e-2	1.000000e+0	1.000000e+0	4.241854e+1	2.357460e-2	1	2.357460e-2	1.000000e+0	85	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	NHP2
Human Phenotype	HP:0001597	Abnormality of the nail	79	2.408581e-2	1.000000e+0	1.000000e+0	4.151823e+1	2.408581e-2	1	2.408581e-2	1.000000e+0	77	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	NHP2
Human Phenotype	HP:0004349	Reduced bone mineral density	80	2.455397e-2	1.000000e+0	1.000000e+0	4.072661e+1	2.455397e-2	1	2.455397e-2	1.000000e+0	73	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	NHP2
Human Phenotype	HP:0001000	Abnormality of skin pigmentation	81	2.462739e-2	1.000000e+0	1.000000e+0	4.060519e+1	2.462739e-2	1	2.462739e-2	1.000000e+0	82	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	NHP2
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	82	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	90	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	NHP2
Human Phenotype	HP:0000795	Abnormality of the urethra	83	2.625878e-2	1.000000e+0	1.000000e+0	3.808250e+1	2.625878e-2	1	2.625878e-2	1.000000e+0	68	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NHP2
Human Phenotype	HP:0000534	Abnormality of the eyebrow	84	2.637232e-2	1.000000e+0	1.000000e+0	3.791855e+1	2.637232e-2	1	2.637232e-2	1.000000e+0	71	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	NHP2
Human Phenotype	HP:0003271	Visceromegaly	85	2.717827e-2	1.000000e+0	1.000000e+0	3.679410e+1	2.717827e-2	1	2.717827e-2	1.000000e+0	101	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	NHP2
Human Phenotype	HP:0001881	Abnormality of leukocytes	86	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	95	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	NHP2
Human Phenotype	HP:0002031	Abnormality of the esophagus	87	2.788607e-2	1.000000e+0	1.000000e+0	3.586019e+1	2.788607e-2	1	2.788607e-2	1.000000e+0	72	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	NHP2
Human Phenotype	HP:0002719	Recurrent infections	88	2.831519e-2	1.000000e+0	1.000000e+0	3.531673e+1	2.831519e-2	1	2.831519e-2	1.000000e+0	97	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	NHP2
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	89	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	100	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	NHP2
Human Phenotype	HP:0100763	Abnormality of the lymphatic system	90	2.916890e-2	1.000000e+0	1.000000e+0	3.428309e+1	2.916890e-2	1	2.916890e-2	1.000000e+0	96	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	NHP2
Human Phenotype	HP:0000050	Hypoplastic genitalia	91	3.012583e-2	1.000000e+0	1.000000e+0	3.319411e+1	3.012583e-2	1	3.012583e-2	1.000000e+0	73	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	NHP2
Human Phenotype	HP:0003241	Genital hypoplasia	92	3.063069e-2	1.000000e+0	1.000000e+0	3.264699e+1	3.063069e-2	1	3.063069e-2	1.000000e+0	76	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	NHP2
Human Phenotype	HP:0004348	Abnormality of bone mineral density	93	3.181401e-2	1.000000e+0	1.000000e+0	3.143270e+1	3.181401e-2	1	3.181401e-2	1.000000e+0	88	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	NHP2
Human Phenotype	HP:0011843	Abnormality of skeletal physiology	94	3.183243e-2	1.000000e+0	1.000000e+0	3.141451e+1	3.183243e-2	1	3.183243e-2	1.000000e+0	85	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	NHP2
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	95	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	83	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	NHP2
Human Phenotype	HP:0011362	Abnormal hair quantity	96	3.605802e-2	1.000000e+0	1.000000e+0	2.773308e+1	3.605802e-2	1	3.605802e-2	1.000000e+0	94	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	NHP2
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	97	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	93	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	NHP2
Human Phenotype	HP:0011355	Localized skin lesion	98	3.611249e-2	1.000000e+0	1.000000e+0	2.769125e+1	3.611249e-2	1	3.611249e-2	1.000000e+0	99	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	NHP2
Human Phenotype	HP:0010936	Abnormality of the lower urinary tract	99	3.624123e-2	1.000000e+0	1.000000e+0	2.759288e+1	3.624123e-2	1	3.624123e-2	1.000000e+0	91	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	NHP2
Human Phenotype	HP:0010460	Abnormality of the female genitalia	100	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	92	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	NHP2
Human Phenotype	HP:0000518	Cataract	101	3.983177e-2	1.000000e+0	1.000000e+0	2.510559e+1	3.983177e-2	1	3.983177e-2	1.000000e+0	104	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	NHP2
Human Phenotype	HP:0002242	Abnormality of the intestine	102	3.988204e-2	1.000000e+0	1.000000e+0	2.507394e+1	3.988204e-2	1	3.988204e-2	1.000000e+0	102	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	NHP2
Human Phenotype	HP:0000517	Abnormality of the lens	103	4.100359e-2	1.000000e+0	1.000000e+0	2.438811e+1	4.100359e-2	1	4.100359e-2	1.000000e+0	106	4.537010e-2	1.000000e+0	1.000000e+0	2.178865e+1	4.589546e-2	1	414	5.000000e-1	2.415459e-3	unnamed	NHP2
Human Phenotype	HP:0010978	Abnormality of immune system physiology	104	4.120940e-2	1.000000e+0	1.000000e+0	2.426631e+1	4.120940e-2	1	4.120940e-2	1.000000e+0	114	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	NHP2
Human Phenotype	HP:0003330	Abnormal bone structure	105	4.132243e-2	1.000000e+0	1.000000e+0	2.419993e+1	4.132243e-2	1	4.132243e-2	1.000000e+0	103	4.081535e-2	1.000000e+0	1.000000e+0	2.424866e+1	4.123940e-2	1	372	5.000000e-1	2.688172e-3	unnamed	NHP2
Human Phenotype	HP:0000036	Abnormality of the penis	106	4.249983e-2	1.000000e+0	1.000000e+0	2.352951e+1	4.249983e-2	1	4.249983e-2	1.000000e+0	98	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	NHP2
Human Phenotype	HP:0001392	Abnormality of the liver	107	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	120	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	NHP2
Human Phenotype	HP:0002650	Scoliosis	108	4.610557e-2	1.000000e+0	1.000000e+0	2.168935e+1	4.610557e-2	1	4.610557e-2	1.000000e+0	104	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	NHP2
Human Phenotype	HP:0011793	Neoplasm by anatomical site	109	4.811988e-2	1.000000e+0	1.000000e+0	2.078143e+1	4.811988e-2	1	4.811988e-2	1.000000e+0	109	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	NHP2
Human Phenotype	HP:0010674	Abnormality of the curvature of the vertebral column	110	5.014164e-2	1.000000e+0	1.000000e+0	1.994351e+1	5.014164e-2	1	5.014164e-2	1.000000e+0	111	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	NHP2
Human Phenotype	HP:0002664	Neoplasm	111	5.084040e-2	1.000000e+0	1.000000e+0	1.966940e+1	5.084040e-2	1	5.084040e-2	1.000000e+0	112	4.991402e-2	1.000000e+0	1.000000e+0	1.978180e+1	5.055152e-2	1	456	5.000000e-1	2.192982e-3	unnamed	NHP2
Human Phenotype	HP:0000035	Abnormality of the testis	112	5.101368e-2	1.000000e+0	1.000000e+0	1.960258e+1	5.101368e-2	1	5.101368e-2	1.000000e+0	108	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	NHP2
Human Phenotype	HP:0000022	Abnormality of male internal genitalia	113	5.264829e-2	1.000000e+0	1.000000e+0	1.899397e+1	5.264829e-2	1	5.264829e-2	1.000000e+0	110	4.775160e-2	1.000000e+0	1.000000e+0	2.068922e+1	4.833435e-2	1	436	5.000000e-1	2.293578e-3	unnamed	NHP2
Human Phenotype	HP:0000164	Abnormality of the teeth	114	5.299708e-2	1.000000e+0	1.000000e+0	1.886896e+1	5.299708e-2	1	5.299708e-2	1.000000e+0	107	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	NHP2
Human Phenotype	HP:0011121	Abnormality of skin morphology	115	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	121	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NHP2
Human Phenotype	HP:0001595	Abnormality of the hair	116	5.637295e-2	1.000000e+0	1.000000e+0	1.773901e+1	5.637295e-2	1	5.637295e-2	1.000000e+0	117	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	NHP2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	117	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	123	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	NHP2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	118	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	136	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	NHP2
Human Phenotype	HP:0000032	Abnormality of male external genitalia	119	5.856997e-2	1.000000e+0	1.000000e+0	1.707359e+1	5.856997e-2	1	5.856997e-2	1.000000e+0	113	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	NHP2
Human Phenotype	HP:0002088	Abnormality of the lung	120	5.867133e-2	1.000000e+0	1.000000e+0	1.704410e+1	5.867133e-2	1	5.867133e-2	1.000000e+0	131	6.990679e-2	1.000000e+0	1.000000e+0	1.405062e+1	7.117122e-2	1	642	5.000000e-1	1.557632e-3	unnamed	NHP2
Human Phenotype	HP:0000811	Abnormal external genitalia	121	5.948677e-2	1.000000e+0	1.000000e+0	1.681046e+1	5.948677e-2	1	5.948677e-2	1.000000e+0	114	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	NHP2
Human Phenotype	HP:0010461	Abnormality of the male genitalia	122	6.153041e-2	1.000000e+0	1.000000e+0	1.625213e+1	6.153041e-2	1	6.153041e-2	1.000000e+0	116	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	NHP2
Human Phenotype	HP:0004322	Short stature	123	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	122	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	NHP2
Human Phenotype	HP:0000606	Abnormality of the periorbital region	124	6.436496e-2	1.000000e+0	1.000000e+0	1.553640e+1	6.436496e-2	1	6.436496e-2	1.000000e+0	118	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	NHP2
Human Phenotype	HP:0000812	Abnormal internal genitalia	125	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	119	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	NHP2
Human Phenotype	HP:0004328	Abnormality of the anterior segment of the eye	126	6.610995e-2	1.000000e+0	1.000000e+0	1.512632e+1	6.610995e-2	1	6.610995e-2	1.000000e+0	129	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	NHP2
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	127	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	126	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	NHP2
Human Phenotype	HP:0000002	Abnormality of body height	128	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	127	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	NHP2
Human Phenotype	HP:0011138	Abnormality of skin adnexa	129	6.863693e-2	1.000000e+0	1.000000e+0	1.456942e+1	6.863693e-2	1	6.863693e-2	1.000000e+0	129	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	NHP2
Human Phenotype	HP:0000925	Abnormality of the vertebral column	130	6.929502e-2	1.000000e+0	1.000000e+0	1.443105e+1	6.929502e-2	1	6.929502e-2	1.000000e+0	124	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NHP2
Human Phenotype	HP:0002715	Abnormality of the immune system	131	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	140	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	NHP2
Human Phenotype	HP:0001249	Intellectual disability	132	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	124	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NHP2
Human Phenotype	HP:0012243	Abnormal genital system morphology	133	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	128	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	NHP2
Human Phenotype	HP:0000365	Hearing impairment	134	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	133	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	NHP2
Human Phenotype	HP:0000364	Hearing abnormality	135	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	134	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	NHP2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	136	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	137	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NHP2
Human Phenotype	HP:0100547	Abnormality of the forebrain	137	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	139	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	NHP2
Human Phenotype	HP:0001510	Growth delay	138	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	137	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NHP2
Human Phenotype	HP:0000078	Abnormality of the genital system	139	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	135	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	NHP2
Human Phenotype	HP:0011354	Generalized abnormality of skin	140	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	144	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	NHP2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	141	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	142	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	NHP2
Human Phenotype	HP:0000284	Abnormality of the ocular region	142	8.041999e-2	1.000000e+0	1.000000e+0	1.243472e+1	8.041999e-2	1	8.041999e-2	1.000000e+0	132	7.204389e-2	1.000000e+0	1.000000e+0	1.362613e+1	7.338839e-2	1	662	5.000000e-1	1.510574e-3	unnamed	NHP2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	143	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	145	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	NHP2
Human Phenotype	HP:0000079	Abnormality of the urinary system	144	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	143	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	NHP2
Human Phenotype	HP:0000163	Abnormality of the oral cavity	145	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	141	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	NHP2
Human Phenotype	HP:0012443	Abnormality of the brain	146	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	147	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	NHP2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	147	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	148	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	NHP2
Human Phenotype	HP:0000951	Abnormality of the skin	148	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	150	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	NHP2
Human Phenotype	HP:0000153	Abnormality of the mouth	149	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	146	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	NHP2
Human Phenotype	HP:0000598	Abnormality of the ear	150	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	149	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	NHP2
Human Phenotype	HP:0012373	Abnormal eye physiology	151	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	151	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	NHP2
Human Phenotype	HP:0012374	Abnormality of the globe	152	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	152	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	NHP2
Human Phenotype	HP:0012372	Abnormal eye morphology	153	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	154	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	NHP2
Human Phenotype	HP:0001507	Growth abnormality	154	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	153	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	NHP2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	155	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	155	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	NHP2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	156	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	162	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	NHP2
Human Phenotype	HP:0001438	Abnormality of the abdomen	157	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	158	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	NHP2
Human Phenotype	HP:0001574	Abnormality of the integument	158	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	157	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	NHP2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	159	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	159	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	NHP2
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	160	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	156	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	NHP2
Human Phenotype	HP:0100543	Cognitive impairment	161	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	160	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	NHP2
Human Phenotype	HP:0000271	Abnormality of the face	162	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	161	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	NHP2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	163	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	169	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	NHP2
Human Phenotype	HP:0000478	Abnormality of the eye	164	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	163	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	NHP2
Human Phenotype	HP:0011446	Abnormality of higher mental function	165	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	164	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	NHP2
Human Phenotype	HP:0000234	Abnormality of the head	166	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	166	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	NHP2
Human Phenotype	HP:0000152	Abnormality of head and neck	167	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	167	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	NHP2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	168	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	165	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	NHP2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	169	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	168	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	NHP2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	170	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	170	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	NHP2
Human Phenotype	HP:0000707	Abnormality of the nervous system	171	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	171	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	NHP2
Human Phenotype	HP:0000005	Mode of inheritance	172	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	172	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	NHP2
Human Phenotype	HP:0000118	Phenotypic abnormality	173	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	173	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	NHP2
Human Phenotype	HP:0000001	All	174	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	174	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	NHP2
Disease Ontology	DOID:2729	dyskeratosis congenita	1	1.259497e-4	2.814976e-1	2.814976e-1	7.939679e+3	1.259497e-4	1	1.259497e-4	1.000000e+0	1	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NHP2
Disease Ontology	DOID:1698	genetic skin disease	2	1.736653e-2	1.000000e+0	1.000000e+0	5.758203e+1	1.736653e-2	1	1.736653e-2	1.000000e+0	2	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	NHP2
Disease Ontology	DOID:37	skin disease	3	5.172018e-2	1.000000e+0	1.000000e+0	1.933481e+1	5.172018e-2	1	5.172018e-2	1.000000e+0	3	6.733902e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	618	5.000000e-1	1.618123e-3	unnamed	NHP2
Disease Ontology	DOID:16	integumentary system disease	4	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	4	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	NHP2
Disease Ontology	DOID:162	cancer	5	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	5	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	NHP2
Disease Ontology	DOID:7	disease of anatomical entity	6	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	6	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	NHP2
Disease Ontology	DOID:4	disease	7	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	7	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_GSPT1	Neighborhood of GSPT1	1	2.556024e-3	1.000000e+0	1.000000e+0	3.912326e+2	2.556024e-3	1	2.556024e-3	1.000000e+0	1	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_FEN1	Neighborhood of FEN1	2	4.520569e-3	1.000000e+0	9.651415e-1	2.212111e+2	4.520569e-3	1	4.520569e-3	1.000000e+0	2	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_UNG	Neighborhood of UNG	3	5.151025e-3	1.000000e+0	7.331626e-1	1.941361e+2	5.151025e-3	1	5.151025e-3	1.000000e+0	3	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_PTPN11	Neighborhood of PTPN11	4	6.198230e-3	1.000000e+0	6.616611e-1	1.613364e+2	6.198230e-3	1	6.198230e-3	1.000000e+0	4	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_CSNK2B	Neighborhood of CSNK2B	5	1.463860e-2	1.000000e+0	1.000000e+0	6.831256e+1	1.463860e-2	1	1.463860e-2	1.000000e+0	6	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	NHP2
MSigDB Cancer Neighborhood	MORF_SOD1	Neighborhood of SOD1	6	1.778344e-2	1.000000e+0	1.000000e+0	5.623208e+1	1.778344e-2	1	1.778344e-2	1.000000e+0	5	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	NHP2
MSigDB Pathway	REACTOME_EXTENSION_OF_TELOMERES	Genes involved in Extension of Telomeres	1	1.772893e-3	1.000000e+0	1.000000e+0	5.640497e+2	1.772893e-3	1	1.772893e-3	1.000000e+0	1	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NHP2
MSigDB Pathway	REACTOME_TELOMERE_MAINTENANCE	Genes involved in Telomere Maintenance	2	3.002843e-3	1.000000e+0	1.000000e+0	3.330177e+2	3.002843e-3	1	3.002843e-3	1.000000e+0	2	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NHP2
MSigDB Pathway	REACTOME_CHROMOSOME_MAINTENANCE	Genes involved in Chromosome Maintenance	3	6.195857e-3	1.000000e+0	1.000000e+0	1.613982e+2	6.195857e-3	1	6.195857e-3	1.000000e+0	3	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	NHP2
MSigDB Pathway	REACTOME_CELL_CYCLE	Genes involved in Cell Cycle	4	2.729338e-2	1.000000e+0	1.000000e+0	3.663892e+1	2.729338e-2	1	2.729338e-2	1.000000e+0	4	4.406985e-2	1.000000e+0	1.000000e+0	2.243905e+1	4.456516e-2	1	402	5.000000e-1	2.487562e-3	unnamed	NHP2
MGI Expression: Detected	16163	TS22_pancreas mesenchyme	1	8.333672e-3	1.000000e+0	1.000000e+0	1.199951e+2	8.333672e-3	1	8.333672e-3	1.000000e+0	1	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NHP2
MGI Expression: Detected	7553	TS23_axial muscle	2	1.540519e-2	1.000000e+0	1.000000e+0	6.491317e+1	1.540519e-2	1	1.540519e-2	1.000000e+0	2	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	NHP2
MGI Expression: Detected	8659	TS23_orbitosphenoid bone	3	6.077818e-2	1.000000e+0	1.000000e+0	1.645327e+1	6.077818e-2	1	6.077818e-2	1.000000e+0	3	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	NHP2
MGI Expression: Detected	7712	TS23_viscerocranium	4	6.436124e-2	1.000000e+0	1.000000e+0	1.553730e+1	6.436124e-2	1	6.436124e-2	1.000000e+0	4	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	NHP2
MGI Expression: Detected	7465	TS23_vertebral axis muscle system	5	7.743613e-2	1.000000e+0	1.000000e+0	1.291387e+1	7.743613e-2	1	7.743613e-2	1.000000e+0	5	7.247101e-2	1.000000e+0	1.000000e+0	1.354429e+1	7.383183e-2	1	666	5.000000e-1	1.501502e-3	unnamed	NHP2
MGI Expression: Detected	7529	TS23_cranium	6	8.417265e-2	1.000000e+0	1.000000e+0	1.188034e+1	8.417265e-2	1	8.417265e-2	1.000000e+0	6	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	NHP2
MGI Expression: Detected	7461	TS23_skeleton	7	1.459231e-1	1.000000e+0	1.000000e+0	6.852922e+0	1.459231e-1	1	1.459231e-1	1.000000e+0	7	1.363538e-1	1.000000e+0	1.000000e+0	7.074902e+0	1.413447e-1	1	1275	5.000000e-1	7.843137e-4	unnamed	NHP2
MGI Expression: Detected	6048	TS22_pancreas	8	1.480883e-1	1.000000e+0	1.000000e+0	6.752730e+0	1.480883e-1	1	1.480883e-1	1.000000e+0	8	1.441660e-1	1.000000e+0	1.000000e+0	6.676906e+0	1.497700e-1	1	1351	5.000000e-1	7.401925e-4	unnamed	NHP2
MGI Expression: Detected	6020	TS22_gut	9	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	9	2.480816e-1	1.000000e+0	1.000000e+0	3.763246e+0	2.657281e-1	1	2397	5.000000e-1	4.171882e-4	unnamed	NHP2
MGI Expression: Detected	6019	TS22_alimentary system	10	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	10	2.795646e-1	1.000000e+0	1.000000e+0	3.306635e+0	3.024223e-1	1	2728	5.000000e-1	3.665689e-4	unnamed	NHP2
MGI Expression: Detected	6018	TS22_visceral organ	11	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	11	3.321114e-1	1.000000e+0	1.000000e+0	2.735972e+0	3.655008e-1	1	3297	5.000000e-1	3.033060e-4	unnamed	NHP2
MGI Expression: Detected	5784	TS22_organ system	12	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	12	4.454434e-1	1.000000e+0	1.000000e+0	1.958424e+0	5.106147e-1	1	4606	5.000000e-1	2.171081e-4	unnamed	NHP2
MGI Expression: Detected	5741	TS22_embryo	13	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	13	4.751674e-1	1.000000e+0	1.000000e+0	1.814625e+0	5.510781e-1	1	4971	5.000000e-1	2.011668e-4	unnamed	NHP2
MGI Expression: Detected	5740	Theiler_stage_22	14	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	14	4.770932e-1	1.000000e+0	1.000000e+0	1.805906e+0	5.537387e-1	1	4995	5.000000e-1	2.002002e-4	unnamed	NHP2
MGI Expression: Detected	6925	TS23_embryo	15	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	15	7.337668e-1	1.000000e+0	1.000000e+0	1.033039e+0	9.680173e-1	1	8732	5.000000e-1	1.145213e-4	unnamed	NHP2
MGI Expression: Detected	6924	Theiler_stage_23	16	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	16	7.339383e-1	1.000000e+0	1.000000e+0	1.032685e+0	9.683499e-1	1	8735	5.000000e-1	1.144820e-4	unnamed	NHP2
MSigDB Perturbation	SAGIV_CD24_TARGETS_UP	Genes up-regulated in HT29 cells (colon cancer) after knockdown of CD24 [GeneID=100133941] by both RNAi and monoclonal antibodies.	1	2.101200e-3	1.000000e+0	1.000000e+0	4.759186e+2	2.101200e-3	1	2.101200e-3	1.000000e+0	1	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	N4BP3
MSigDB Perturbation	SAGIV_CD24_TARGETS_DN	Genes down-regulated in HT29 cells (colon cancer) after knockdown of CD24 [GeneID=100133941] by both RNAi and monoclonal antibodies.	2	2.944259e-3	1.000000e+0	1.000000e+0	3.396441e+2	2.944259e-3	1	2.944259e-3	1.000000e+0	4	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	N4BP3
MSigDB Perturbation	BILANGES_RAPAMYCIN_SENSITIVE_GENES	Genes translationally regulated in MEF cells (embryonic fibroblasts) by rapamycin (sirolimus) [PubChemID=6610346] but not in response to serum deprivation.	3	3.240392e-3	1.000000e+0	1.000000e+0	3.086046e+2	3.240392e-3	1	3.240392e-3	1.000000e+0	2	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	N4BP3
MSigDB Perturbation	BURTON_ADIPOGENESIS_4	Progressively up-regulated from 8-48 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.	4	3.531542e-3	1.000000e+0	1.000000e+0	2.831624e+2	3.531542e-3	1	3.531542e-3	1.000000e+0	5	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	NHP2
MSigDB Perturbation	TONG_INTERACT_WITH_PTTG1	Proteins that interact with PTTG1 [GeneID=9232], based on protein array.	5	3.901429e-3	1.000000e+0	1.000000e+0	2.563163e+2	3.901429e-3	1	3.901429e-3	1.000000e+0	6	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NHP2
MSigDB Perturbation	SMITH_LIVER_CANCER	Potential marker genes specifically up-regulated in the majority of hepatocellular carcinoma (HCC) tumors.	6	4.727906e-3	1.000000e+0	1.000000e+0	2.115101e+2	4.727906e-3	1	4.727906e-3	1.000000e+0	3	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	NHP2
MSigDB Perturbation	RAMASWAMY_METASTASIS_UP	Up-regulated genes in metastatic vs primary solid tumors.	7	5.298113e-3	1.000000e+0	1.000000e+0	1.887464e+2	5.298113e-3	1	5.298113e-3	1.000000e+0	7	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NHP2
MSigDB Perturbation	JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	Genes down-regulated in 745A cells (erythroleukemia) upon knockdown of FLI1 [GeneID=2313] by RNAi and down-regulation of SPI1 [GeneID=6688] by HMBA [PubChemID=3616].	8	6.481539e-3	1.000000e+0	1.000000e+0	1.542843e+2	6.481539e-3	1	6.481539e-3	1.000000e+0	8	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NHP2
MSigDB Perturbation	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 14.	9	9.205728e-3	1.000000e+0	1.000000e+0	1.086280e+2	9.205728e-3	1	9.205728e-3	1.000000e+0	13	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	NHP2
MSigDB Perturbation	DARWICHE_SKIN_TUMOR_PROMOTER_UP	Genes up-regulated during skin tumor progression: epidermis treated with the carcinogen DMBA [PubChem=6001] followed by 20 weekly applications of the tumor promoter TPA [PubChem=4792], compared to the untreated skin.	10	9.796613e-3	1.000000e+0	1.000000e+0	1.020761e+2	9.796613e-3	1	9.796613e-3	1.000000e+0	11	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	NHP2
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_HIGH_UP	Genes up-regulated during skin tumor progression from normal skin to high risk papilloma.	11	1.029191e-2	1.000000e+0	1.000000e+0	9.716370e+1	1.029191e-2	1	1.029191e-2	1.000000e+0	14	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	NHP2
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_LOW_UP	Genes up-regulated during skin tumor progression from low risk papilloma vs normal skin.	12	1.129285e-2	1.000000e+0	1.000000e+0	8.855161e+1	1.129285e-2	1	1.129285e-2	1.000000e+0	16	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	NHP2
MSigDB Perturbation	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	Genes up-regulated in squamous cell carcinoma (SCC) compared to normal skin.	13	1.138715e-2	1.000000e+0	1.000000e+0	8.781828e+1	1.138715e-2	1	1.138715e-2	1.000000e+0	12	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	NHP2
MSigDB Perturbation	SANSOM_APC_TARGETS_REQUIRE_MYC	Genes up-regulated after Cre-lox knockout of APC [GeneID=324] in the small intestine that require functional MYC [GeneID=4609].	14	1.395357e-2	1.000000e+0	1.000000e+0	7.166627e+1	1.395357e-2	1	1.395357e-2	1.000000e+0	20	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	NHP2
MSigDB Perturbation	LE_EGR2_TARGETS_UP	Genes up-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959].	15	1.431208e-2	1.000000e+0	1.000000e+0	6.987106e+1	1.431208e-2	1	1.431208e-2	1.000000e+0	10	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	NHP2
MSigDB Perturbation	SANSOM_APC_MYC_TARGETS	Genes down-regulated after double Cre-lox knockout  of both APC and MYC [GeneID=324;4609] in small intestine.	16	1.449228e-2	1.000000e+0	1.000000e+0	6.900225e+1	1.449228e-2	1	1.449228e-2	1.000000e+0	22	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	NHP2
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	Genes up-regulated in monocytes by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	17	1.693383e-2	1.000000e+0	1.000000e+0	5.905338e+1	1.693383e-2	1	1.693383e-2	1.000000e+0	19	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NHP2
MSigDB Perturbation	GOLDRATH_HOMEOSTATIC_PROLIFERATION	Up-regulated in CD8+ [GeneID=925] T lymphocytes undergoing homeostatic proliferation (HP) versus the naive cells; these genes are not up-regulated versus effector or memory cell population.	18	1.696519e-2	1.000000e+0	1.000000e+0	5.894422e+1	1.696519e-2	1	1.696519e-2	1.000000e+0	17	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	NHP2
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	Genes down-regulated in MCF7 cells (breast cancer) at 6 h of estradiol [PubChemID=5757] treatment.	19	1.805031e-2	1.000000e+0	1.000000e+0	5.540070e+1	1.805031e-2	1	1.805031e-2	1.000000e+0	9	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	N4BP3
MSigDB Perturbation	ALONSO_METASTASIS_UP	Up-regulated genes in melanoma tumous that developed metastatic disease compared to primary melanoma that did not.	20	1.864850e-2	1.000000e+0	1.000000e+0	5.362362e+1	1.864850e-2	1	1.864850e-2	1.000000e+0	23	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	NHP2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_24HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 24 h time point that were not down-regulated at the previous time point, 20 h.	21	2.140487e-2	1.000000e+0	1.000000e+0	4.671834e+1	2.140487e-2	1	2.140487e-2	1.000000e+0	15	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	N4BP3
MSigDB Perturbation	WONG_EMBRYONIC_STEM_CELL_CORE	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	22	2.401219e-2	1.000000e+0	1.000000e+0	4.164551e+1	2.401219e-2	1	2.401219e-2	1.000000e+0	27	3.701143e-2	1.000000e+0	1.000000e+0	2.676706e+1	3.735935e-2	1	337	5.000000e-1	2.967359e-3	unnamed	NHP2
MSigDB Perturbation	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	Genes down-regulated in SH-SY5Y cells (neuroblastoma) after treatment with epoxomicin [PubChem=3035402], a protease inhibitor causing apoptosis.	23	2.505742e-2	1.000000e+0	1.000000e+0	3.990833e+1	2.505742e-2	1	2.505742e-2	1.000000e+0	18	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	NHP2
MSigDB Perturbation	WANG_TUMOR_INVASIVENESS_UP	Up-regulated genes in the subpopulation of invasive PyMT cells (breast cancer) compared to the general population of PyMT cells.	24	2.560718e-2	1.000000e+0	1.000000e+0	3.905154e+1	2.560718e-2	1	2.560718e-2	1.000000e+0	28	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	NHP2
MSigDB Perturbation	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	Genes up-regulated in biphasic (mixed) vs epithelial subtypes of malignant peritoneal mesothelioma.	25	2.747149e-2	1.000000e+0	1.000000e+0	3.640137e+1	2.747149e-2	1	2.747149e-2	1.000000e+0	24	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	NHP2
MSigDB Perturbation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	26	2.928641e-2	1.000000e+0	1.000000e+0	3.414553e+1	2.928641e-2	1	2.928641e-2	1.000000e+0	30	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	NHP2
MSigDB Perturbation	MANALO_HYPOXIA_UP	Genes up-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].	27	2.970945e-2	1.000000e+0	1.000000e+0	3.365933e+1	2.970945e-2	1	2.970945e-2	1.000000e+0	20	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	N4BP3
MSigDB Perturbation	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	Genes down-regulated in ALL (acute lymphoblastic leukemia) blasts after 1 week of treatment with glucocorticoids.	28	3.771906e-2	1.000000e+0	1.000000e+0	2.651180e+1	3.771906e-2	1	3.771906e-2	1.000000e+0	29	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	NHP2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_14HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 14 h time point that were not down-regulated at the previous time point, 12 h.	29	3.849897e-2	1.000000e+0	1.000000e+0	2.597472e+1	3.849897e-2	1	3.849897e-2	1.000000e+0	25	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	N4BP3
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_CLASSES_UP	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	30	3.989950e-2	1.000000e+0	1.000000e+0	2.506297e+1	3.989950e-2	1	3.989950e-2	1.000000e+0	37	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	NHP2
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	31	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	39	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	NHP2
MSigDB Perturbation	PHONG_TNF_RESPONSE_NOT_VIA_P38	Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were not affected by p38 inhibitor LY479754.	32	4.385350e-2	1.000000e+0	1.000000e+0	2.280320e+1	4.385350e-2	1	4.385350e-2	1.000000e+0	26	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	N4BP3
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_UP	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	33	5.123973e-2	1.000000e+0	1.000000e+0	1.951611e+1	5.123973e-2	1	5.123973e-2	1.000000e+0	35	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	NHP2
MSigDB Perturbation	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	Genes changed between developmental stages of Valpha14i  natural killer T lymphocyte cells (NKT).	34	5.281432e-2	1.000000e+0	1.000000e+0	1.893426e+1	5.281432e-2	1	5.281432e-2	1.000000e+0	32	5.077830e-2	1.000000e+0	1.000000e+0	1.944073e+1	5.143839e-2	1	464	5.000000e-1	2.155172e-3	unnamed	NHP2
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME2	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation mark at K4 (H3K4me2) in neural precursor cells (NPC).	35	5.352102e-2	1.000000e+0	1.000000e+0	1.868425e+1	5.352102e-2	1	5.352102e-2	1.000000e+0	31	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	N4BP3
MSigDB Perturbation	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	Genes up-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).	36	5.507944e-2	1.000000e+0	1.000000e+0	1.815559e+1	5.507944e-2	1	5.507944e-2	1.000000e+0	36	6.090412e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	558	5.000000e-1	1.792115e-3	unnamed	NHP2
MSigDB Perturbation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	Genes down-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.	37	5.646356e-2	1.000000e+0	1.000000e+0	1.771054e+1	5.646356e-2	1	5.646356e-2	1.000000e+0	38	6.766019e-2	1.000000e+0	1.000000e+0	1.452576e+1	6.884319e-2	1	621	5.000000e-1	1.610306e-3	unnamed	NHP2
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	38	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	42	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	NHP2
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	The 'group 1 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	39	5.895188e-2	1.000000e+0	1.000000e+0	1.696299e+1	5.895188e-2	1	5.895188e-2	1.000000e+0	33	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	NHP2
MSigDB Perturbation	PATIL_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	40	5.982431e-2	1.000000e+0	1.000000e+0	1.671561e+1	5.982431e-2	1	5.982431e-2	1.000000e+0	40	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NHP2
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	41	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	43	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	NHP2
MSigDB Perturbation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	Genes with promoters bound by both PPARG and RXRA [GeneID=5468, 6256] at 8 day time point of adipocyte differentiation of 3T3-L1 cells (preadipocyte).	42	6.300120e-2	1.000000e+0	1.000000e+0	1.587271e+1	6.300120e-2	1	6.300120e-2	1.000000e+0	46	9.496795e-2	1.000000e+0	1.000000e+0	1.027392e+1	9.733385e-2	1	878	5.000000e-1	1.138952e-3	unnamed	N4BP3
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	43	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	45	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	NHP2
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	Genes down-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	44	7.665633e-2	1.000000e+0	1.000000e+0	1.304524e+1	7.665633e-2	1	7.665633e-2	1.000000e+0	34	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	N4BP3
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	45	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	47	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	NHP2
MSigDB Perturbation	LEE_BMP2_TARGETS_DN	Genes down-regulated in uterus upon knockout of BMP2 [GeneID=650].	46	8.052857e-2	1.000000e+0	1.000000e+0	1.241795e+1	8.052857e-2	1	8.052857e-2	1.000000e+0	44	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	NHP2
MSigDB Perturbation	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	Genes whose DNA is hyper-methylated in hepatocellular carcinoma (HCC) compared to normal liver.	47	1.007221e-1	1.000000e+0	1.000000e+0	9.928311e+0	1.007221e-1	1	1.007221e-1	1.000000e+0	41	8.460275e-2	1.000000e+0	1.000000e+0	1.156474e+1	8.646971e-2	1	780	5.000000e-1	1.282051e-3	unnamed	N4BP3
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	48	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	49	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	NHP2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	49	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	50	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	NHP2
MSigDB Perturbation	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation at K4 (H3K4me2) and trimethylation at K27 (H3K27me3) in brain.	50	1.581088e-1	1.000000e+0	1.000000e+0	6.324759e+0	1.581088e-1	1	1.581088e-1	1.000000e+0	48	1.118684e-1	1.000000e+0	1.000000e+0	8.681906e+0	1.151821e-1	1	1039	5.000000e-1	9.624639e-4	unnamed	N4BP3
MSigDB miRNA Motifs	TCCCCAC,MIR-491	Targets of MicroRNA TCCCCAC,MIR-491	1	6.482200e-3	1.000000e+0	1.000000e+0	1.542686e+2	6.482200e-3	1	6.482200e-3	1.000000e+0	1	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	N4BP3
MSigDB miRNA Motifs	GGTGTGT,MIR-329	Targets of MicroRNA GGTGTGT,MIR-329	2	1.633291e-2	1.000000e+0	1.000000e+0	6.122606e+1	1.633291e-2	1	1.633291e-2	1.000000e+0	3	1.204742e-2	1.000000e+0	8.874933e-1	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	N4BP3
MSigDB miRNA Motifs	AGGTGCA,MIR-500	Targets of MicroRNA AGGTGCA,MIR-500	3	1.647447e-2	1.000000e+0	1.000000e+0	6.069997e+1	1.647447e-2	1	1.647447e-2	1.000000e+0	2	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	NHP2
InterPro	IPR002415	H/ACA ribonucleoprotein complex, subunit Nhp2, eukaryote	1	5.341851e-5	5.033092e-1	5.033092e-1	1.872010e+4	5.341851e-5	1	5.341851e-5	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	NHP2
InterPro	IPR018492	Ribosomal protein L7Ae/L8/Nhp2 family	2	5.633986e-5	5.308342e-1	2.654171e-1	1.774942e+4	5.633986e-5	1	5.633986e-5	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	NHP2
InterPro	IPR004038	Ribosomal protein L7Ae/L30e/S12e/Gadd45	3	8.968706e-4	1.000000e+0	1.000000e+0	1.114988e+3	8.968706e-4	1	8.968706e-4	1.000000e+0	3	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	NHP2
TreeFam	TF105839	nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs)	1	2.972863e-5	2.415748e-1	2.415748e-1	3.363760e+4	2.972863e-5	1	2.972863e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NHP2
TreeFam	TF331420	ENSG00000088899, LZTS1, LZTS2, N4BP3	2	4.646528e-4	1.000000e+0	1.000000e+0	2.152144e+3	4.646528e-4	1	4.646528e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	N4BP3
Ensembl Genes	15879	NHP2	1	2.972863e-5	5.363342e-1	5.363342e-1	3.363760e+4	2.972863e-5	1	2.972863e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NHP2
Ensembl Genes	15877	N4BP3	2	5.302568e-5	9.566363e-1	4.783181e-1	1.885879e+4	5.302568e-5	1	5.302568e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	1	1.079431e-2	1.000000e+0	1.000000e+0	9.264141e+1	1.079431e-2	1	1.079431e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP	Genes up-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 60 min.	2	1.204262e-2	1.000000e+0	1.000000e+0	8.303843e+1	1.204262e-2	1	1.204262e-2	1.000000e+0	5	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 12 h.	3	1.221212e-2	1.000000e+0	1.000000e+0	8.188584e+1	1.221212e-2	1	1.221212e-2	1.000000e+0	22	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells KRLG1 Int [GeneID=10219] vs those with KRLG1 Hi.	4	1.253498e-2	1.000000e+0	1.000000e+0	7.977674e+1	1.253498e-2	1	1.253498e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with poly(I:C) (TLR3 agonist) at 12 h.	5	1.261416e-2	1.000000e+0	1.000000e+0	7.927599e+1	1.261416e-2	1	1.261416e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	6	1.272064e-2	1.000000e+0	1.000000e+0	7.861239e+1	1.272064e-2	1	1.272064e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.	7	1.332361e-2	1.000000e+0	1.000000e+0	7.505475e+1	1.332361e-2	1	1.332361e-2	1.000000e+0	6	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with poly(I:C) (TLR3 agonist) at 8 h.	8	1.343291e-2	1.000000e+0	1.000000e+0	7.444404e+1	1.343291e-2	1	1.343291e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with CpG DNA (TLR9 agonist) at 1 h.	9	1.347220e-2	1.000000e+0	1.000000e+0	7.422695e+1	1.347220e-2	1	1.347220e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 8 h.	10	1.351280e-2	1.000000e+0	1.000000e+0	7.400389e+1	1.351280e-2	1	1.351280e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 24 h.	11	1.357048e-2	1.000000e+0	1.000000e+0	7.368937e+1	1.357048e-2	1	1.357048e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	12	1.367515e-2	1.000000e+0	1.000000e+0	7.312536e+1	1.367515e-2	1	1.367515e-2	1.000000e+0	22	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 4 h.	13	1.368123e-2	1.000000e+0	1.000000e+0	7.309282e+1	1.368123e-2	1	1.368123e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.	14	1.368185e-2	1.000000e+0	1.000000e+0	7.308953e+1	1.368185e-2	1	1.368185e-2	1.000000e+0	82	2.237830e-2	1.000000e+0	5.212506e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with CpG DNA (TLR9 agonist) at 6 h.	15	1.384869e-2	1.000000e+0	1.000000e+0	7.220899e+1	1.384869e-2	1	1.384869e-2	1.000000e+0	33	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with CpG DNA (TLR9 agonist) at 8 h.	16	1.419591e-2	1.000000e+0	1.000000e+0	7.044282e+1	1.419591e-2	1	1.419591e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	17	1.448543e-2	1.000000e+0	1.000000e+0	6.903490e+1	1.448543e-2	1	1.448543e-2	1.000000e+0	74	2.183015e-2	1.000000e+0	5.634539e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 24 h.	18	1.458676e-2	1.000000e+0	1.000000e+0	6.855531e+1	1.458676e-2	1	1.458676e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 24 h.	19	1.466399e-2	1.000000e+0	1.000000e+0	6.819427e+1	1.466399e-2	1	1.466399e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_4H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with poly(I:C) (TLR3 agonist) at 4 h.	20	1.469944e-2	1.000000e+0	1.000000e+0	6.802981e+1	1.469944e-2	1	1.469944e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE5960_TH1_VS_ANERGIC_TH1_UP	Genes up-regulated in comparison of anergy induced CD4 [GeneID=920] T cells versus conventional CD4 [GeneID=920] T cells.	21	1.472860e-2	1.000000e+0	1.000000e+0	6.789513e+1	1.472860e-2	1	1.472860e-2	1.000000e+0	74	2.183015e-2	1.000000e+0	5.634539e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_NKCELL_DN	Genes down-regulated in comparison of neutrophils versus NK cells.	22	1.494963e-2	1.000000e+0	1.000000e+0	6.689129e+1	1.494963e-2	1	1.494963e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE14308_TH1_VS_NATURAL_TREG_UP	Genes up-regulated in comparison of Th1 cells versus natural regulatory T cell (Treg).	23	1.502918e-2	1.000000e+0	1.000000e+0	6.653722e+1	1.502918e-2	1	1.502918e-2	1.000000e+0	8	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	24	1.504942e-2	1.000000e+0	1.000000e+0	6.644772e+1	1.504942e-2	1	1.504942e-2	1.000000e+0	74	2.183015e-2	1.000000e+0	5.634539e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Gardiquimod (TLR7 agonist) at 1 h.	25	1.505341e-2	1.000000e+0	1.000000e+0	6.643014e+1	1.505341e-2	1	1.505341e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL6 [GeneID=3569].	26	1.506767e-2	1.000000e+0	1.000000e+0	6.636728e+1	1.506767e-2	1	1.506767e-2	1.000000e+0	33	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of mast cells versus neutrophils.	27	1.507882e-2	1.000000e+0	1.000000e+0	6.631818e+1	1.507882e-2	1	1.507882e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 48 h after stimulation with IL12.	28	1.510333e-2	1.000000e+0	1.000000e+0	6.621059e+1	1.510333e-2	1	1.510333e-2	1.000000e+0	80	2.204943e-2	1.000000e+0	5.264301e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to T. gondii.	29	1.517197e-2	1.000000e+0	9.992573e-1	6.591102e+1	1.517197e-2	1	1.517197e-2	1.000000e+0	85	2.270712e-2	1.000000e+0	5.102423e-1	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_DN	Genes down-regulated in comparison of dendritic cells (DC) versus untreated macrophages.	30	1.518007e-2	1.000000e+0	9.664645e-1	6.587584e+1	1.518007e-2	1	1.518007e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 8 h.	31	1.520446e-2	1.000000e+0	9.367909e-1	6.577018e+1	1.520446e-2	1	1.520446e-2	1.000000e+0	33	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	32	1.526010e-2	1.000000e+0	9.108372e-1	6.553037e+1	1.526010e-2	1	1.526010e-2	1.000000e+0	8	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_TH1_DN	Genes down-regulated in comparison of neutrophils versus Th1 cells.	33	1.535323e-2	1.000000e+0	8.886263e-1	6.513286e+1	1.535323e-2	1	1.535323e-2	1.000000e+0	22	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	34	1.545615e-2	1.000000e+0	8.682720e-1	6.469917e+1	1.545615e-2	1	1.545615e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with LPS (TLR4 agonist) at 1 h.	35	1.546965e-2	1.000000e+0	8.442009e-1	6.464272e+1	1.546965e-2	1	1.546965e-2	1.000000e+0	83	2.248791e-2	1.000000e+0	5.174929e-1	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus CD4 [GeneID=920] Int CD8 thymocytes.	36	1.568037e-2	1.000000e+0	8.319307e-1	6.377401e+1	1.568037e-2	1	1.568037e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_TH1_DN	Genes down-regulated in comparison of eosinophils versus Th1 cells.	37	1.574345e-2	1.000000e+0	8.127024e-1	6.351848e+1	1.574345e-2	1	1.574345e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h.	38	1.576242e-2	1.000000e+0	7.922690e-1	6.344202e+1	1.576242e-2	1	1.576242e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_8H_LPS_DC_UP	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	39	1.576937e-2	1.000000e+0	7.722948e-1	6.341407e+1	1.576937e-2	1	1.576937e-2	1.000000e+0	7	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE27786_CD4_TCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells versus monocyte macrophages.	40	1.594602e-2	1.000000e+0	7.614225e-1	6.271157e+1	1.594602e-2	1	1.594602e-2	1.000000e+0	33	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	Genes up-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.	41	1.604898e-2	1.000000e+0	7.476476e-1	6.230927e+1	1.604898e-2	1	1.604898e-2	1.000000e+0	8	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_CD4_TCELL_UP	Genes up-regulated in comparison of lineage negative versus CD4 [GeneID=920] T cells.	42	1.632330e-2	1.000000e+0	7.423215e-1	6.126213e+1	1.632330e-2	1	1.632330e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to M.tuberculosis.	43	1.637997e-2	1.000000e+0	7.275754e-1	6.105016e+1	1.637997e-2	1	1.637997e-2	1.000000e+0	77	2.193980e-2	1.000000e+0	5.442210e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP	Genes up-regulated in comparison of Homeo Convert versus Homeo Foxp3- (see Table 1S in the paper for details).	44	1.651040e-2	1.000000e+0	7.167015e-1	6.056789e+1	1.651040e-2	1	1.651040e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	45	1.666999e-2	1.000000e+0	7.075485e-1	5.998802e+1	1.666999e-2	1	1.666999e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	46	1.678214e-2	1.000000e+0	6.968236e-1	5.958715e+1	1.678214e-2	1	1.678214e-2	1.000000e+0	81	2.215906e-2	1.000000e+0	5.225161e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	47	1.695740e-2	1.000000e+0	6.891199e-1	5.897129e+1	1.695740e-2	1	1.695740e-2	1.000000e+0	84	2.259752e-2	1.000000e+0	5.138246e-1	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	48	1.704319e-2	1.000000e+0	6.781769e-1	5.867445e+1	1.704319e-2	1	1.704319e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN	Genes down-regulated in comparison of CD4+ [GeneID=920] CD8+ thymocytes versus CD4- [GeneID=920] CD8+ thymocytes.	49	1.717700e-2	1.000000e+0	6.695524e-1	5.821738e+1	1.717700e-2	1	1.717700e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	50	1.718798e-2	1.000000e+0	6.565808e-1	5.818018e+1	1.718798e-2	1	1.718798e-2	1.000000e+0	77	2.193980e-2	1.000000e+0	5.442210e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	51	1.733399e-2	1.000000e+0	6.491749e-1	5.769012e+1	1.733399e-2	1	1.733399e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of granulocytic myeloid derived suppressor cells (MDSC) versus neutrophils.	52	1.746443e-2	1.000000e+0	6.414819e-1	5.725924e+1	1.746443e-2	1	1.746443e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	53	1.749822e-2	1.000000e+0	6.305962e-1	5.714868e+1	1.749822e-2	1	1.749822e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_L_MAJOR_DN	Genes down-regulated in comparison of dendritic cells exposed to L. major versus macrophages exposed to L. major.	54	1.766948e-2	1.000000e+0	6.249761e-1	5.659476e+1	1.766948e-2	1	1.766948e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 24 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 24 h.	55	1.774497e-2	1.000000e+0	6.162344e-1	5.635400e+1	1.774497e-2	1	1.774497e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE14308_TH2_VS_TH17_UP	Genes up-regulated in comparison of Th2 cells versus Th17 cells.	56	1.782663e-2	1.000000e+0	6.080154e-1	5.609586e+1	1.782663e-2	1	1.782663e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE14308_TH1_VS_TH17_UP	Genes up-regulated in comparison of Th1 cells versus Th17 cells.	57	1.786173e-2	1.000000e+0	5.985246e-1	5.598561e+1	1.786173e-2	1	1.786173e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	58	1.791043e-2	1.000000e+0	5.898090e-1	5.583338e+1	1.791043e-2	1	1.791043e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	59	1.794138e-2	1.000000e+0	5.808142e-1	5.573706e+1	1.794138e-2	1	1.794138e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h.	60	1.798644e-2	1.000000e+0	5.725683e-1	5.559743e+1	1.798644e-2	1	1.798644e-2	1.000000e+0	77	2.193980e-2	1.000000e+0	5.442210e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 12 h.	61	1.814749e-2	1.000000e+0	5.682247e-1	5.510404e+1	1.814749e-2	1	1.814749e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE27786_CD8_TCELL_VS_NKTCELL_UP	Genes up-regulated in comparison of CD8 T cells versus NKT cells.	62	1.819109e-2	1.000000e+0	5.604029e-1	5.497196e+1	1.819109e-2	1	1.819109e-2	1.000000e+0	33	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE27786_LSK_VS_NKTCELL_UP	Genes up-regulated in comparison of LSK versus NKT cells.	63	1.839024e-2	1.000000e+0	5.575454e-1	5.437667e+1	1.839024e-2	1	1.839024e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE14308_TH2_VS_NATURAL_TREG_UP	Genes up-regulated in comparison of Th2 cells versus natural regulatory T cell (Treg).	64	1.846005e-2	1.000000e+0	5.509171e-1	5.417105e+1	1.846005e-2	1	1.846005e-2	1.000000e+0	22	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.	65	1.848083e-2	1.000000e+0	5.430521e-1	5.411012e+1	1.848083e-2	1	1.848083e-2	1.000000e+0	67	2.172051e-2	1.000000e+0	6.191966e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	Genes up-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	66	1.865788e-2	1.000000e+0	5.399477e-1	5.359667e+1	1.865788e-2	1	1.865788e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.	67	1.872494e-2	1.000000e+0	5.338005e-1	5.340471e+1	1.872494e-2	1	1.872494e-2	1.000000e+0	2	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	68	1.891202e-2	1.000000e+0	5.312053e-1	5.287643e+1	1.891202e-2	1	1.891202e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.	69	1.920016e-2	1.000000e+0	5.314827e-1	5.208290e+1	1.920016e-2	1	1.920016e-2	1.000000e+0	4	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	Genes up-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.	70	1.942969e-2	1.000000e+0	5.301530e-1	5.146761e+1	1.942969e-2	1	1.942969e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] thymocytes.	71	1.991617e-2	1.000000e+0	5.357730e-1	5.021045e+1	1.991617e-2	1	1.991617e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 40 h versus those from old donors treated with TSST at 40 h.	72	1.995223e-2	1.000000e+0	5.292883e-1	5.011970e+1	1.995223e-2	1	1.995223e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	73	2.022880e-2	1.000000e+0	5.292741e-1	4.943446e+1	2.022880e-2	1	2.022880e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination.	74	2.036041e-2	1.000000e+0	5.255187e-1	4.911492e+1	2.036041e-2	1	2.036041e-2	1.000000e+0	1	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	Genes down-regulated in comparison of eosinophils versus mast cells.	75	2.055038e-2	1.000000e+0	5.233497e-1	4.866091e+1	2.055038e-2	1	2.055038e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	76	2.057159e-2	1.000000e+0	5.169965e-1	4.861073e+1	2.057159e-2	1	2.057159e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	Genes down-regulated in comparison of macrophages versus macrophages exposed to M. tuberculosis.	77	2.114423e-2	1.000000e+0	5.244867e-1	4.729423e+1	2.114423e-2	1	2.114423e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_6H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with LPS (TLR4 agonist) at 6 h.	78	2.124962e-2	1.000000e+0	5.203433e-1	4.705967e+1	2.124962e-2	1	2.124962e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.	79	2.147521e-2	1.000000e+0	5.192108e-1	4.656532e+1	2.147521e-2	1	2.147521e-2	1.000000e+0	57	2.161085e-2	1.000000e+0	7.241530e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	Genes down-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	80	2.158549e-2	1.000000e+0	5.153536e-1	4.632741e+1	2.158549e-2	1	2.158549e-2	1.000000e+0	26	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NHP2
MSigDB Immunologic Signatures	GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	81	2.213425e-2	1.000000e+0	5.219311e-1	4.517885e+1	2.213425e-2	1	2.213425e-2	1.000000e+0	3	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP	Genes up-regulated in comparison of adult thymic progenitors versus fetal thymic progenitors.	82	2.240365e-2	1.000000e+0	5.218411e-1	4.463559e+1	2.240365e-2	1	2.240365e-2	1.000000e+0	47	2.150119e-2	1.000000e+0	8.737718e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 2 h.	83	2.251826e-2	1.000000e+0	5.181913e-1	4.440840e+1	2.251826e-2	1	2.251826e-2	1.000000e+0	38	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL1B [GeneID=3553] and IL6 [GeneID=3569].	84	2.254917e-2	1.000000e+0	5.127252e-1	4.434753e+1	2.254917e-2	1	2.254917e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	N4BP3
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes.	85	2.334868e-2	1.000000e+0	5.246586e-1	4.282898e+1	2.334868e-2	1	2.334868e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NHP2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
